Nano-X Imaging Ltd. Stock Price, News & Analysis

NANO-X IMAGING LTD (NASDAQ: NNOX) has completed its merger with Zebra Medical Vision, Ltd., valued at approximately $110 million, with additional stock options worth up to $84 million contingent on performance milestones. The Company also acquired MDWEB, LLC and USARAD Holdings, Inc. for around $20 million in stock and cash, with potential additional payments of $10 million. These strategic acquisitions aim to enhance Nanox's AI-powered imaging solutions, addressing the global shortage of radiologists and improving healthcare delivery.

NANO-X IMAGING LTD (NNOX) is set to report its third-quarter results for the period ending September 30, 2021, on November 17, 2021, before market opening. Ran Poliakine, the CEO, along with Erez Meltzer, the newly appointed CEO effective January 1, 2022, will lead a conference call at 8:30 a.m. ET to discuss the results and provide a business update. Interested parties can join via phone or webcast. Nanox aims to transform medical imaging with its innovative digital X-ray technology.

NANO-X IMAGING LTD (NNOX) has partnered with International Clinics Group to enhance medical imaging accessibility in Chile, Bolivia, and Peru. This collaboration aims to deploy the Nanox System, which includes the Nanox.ARC imaging device and Nanox.CLOUD services, across various healthcare facilities, subject to regulatory approval. The initiative addresses the shortage of medical imaging in rural areas, where access is limited. The World Health Organization indicates that two-thirds of the global population lacks adequate imaging services, emphasizing the need for such advancements.

NANO-X IMAGING (NNOX) announced the 8th FDA clearance for its Coronary Artery Calcium solution, enhancing its population health offerings via Zebra Medical Vision. This follows a merger agreement with Zebra aimed at expanding AI-based diagnostic capabilities for chronic conditions. Nanox aims to revolutionize medical imaging with its digital X-ray technology, potentially lowering costs and improving access to early detection services. The company highlights risks linked to acquisitions and regulatory clearances in its forward-looking statements.

Zebra Medical Vision has announced its eighth FDA 510(k) clearance for the HealthCCSng solution, designed to quantify coronary artery calcium (CAC) in existing non-gated CT scans to identify patients at risk for cardiovascular disease. This innovation aims to facilitate early diagnosis and treatment, thereby reducing healthcare costs. Zebra-Med's collaboration with Nanox is expected to enhance its AI capabilities and reach, supporting population health management and preventative care. The company emphasizes its commitment to improving healthcare outcomes through advanced imaging technologies.

Nano-X Imaging Ltd (Nasdaq: NNOX) announces an AI Vision event on October 27, 2021, at 8:30am ET. Hosted by Chairman and CEO Ran Poliakine and Director Erez Meltzer, the event will showcase the integration of AI technologies with Nano-X's imaging solutions, Nanox.ARC and Nanox.SOURCE. This initiative aims to enhance medical imaging systems' affordability and accessibility. The company seeks collaborations with healthcare organizations to provide early detection services. For more details, visit www.nanox.vision.

Nanox, a pioneering medical imaging technology company, announced that its CEO, Ran Poliakine, and Executive Chairman, Erez Meltzer, will present at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021, at 9:20 AM ET. A live webcast will be available through the company's website, with a replay accessible afterward. Nanox is focused on revolutionizing medical imaging by developing an affordable digital X-ray source aimed at collaboration with leading healthcare organizations to improve early detection imaging services.

Nanox to Host Business Update Webcast

On August 12, 2021, Nanox, a medical imaging technology company traded under NASDAQ: NNOX, announced a Business Update Video Presentation scheduled for August 16, 2021, at 8:30 am ET. CEO Ran Poliakine and senior leadership will discuss company advancements. Interested participants can register through the provided link. Nanox aims to reduce medical imaging costs with its innovative digital X-ray technology and seeks collaborations for affordable imaging services.

Nanox has announced a merger agreement with Zebra Medical Vision for $100 million upfront and $100 million in milestone payments. Additionally, it has entered a binding letter of intent to acquire USARAD Holdings Inc. for $30 million, comprising $21 million in shares and $9 million cash. These acquisitions aim to create a globally connected radiology solution and enhance population health management. Notably, Zebra Medical brings advanced AI technology and established relationships with healthcare providers worldwide.